Muc16 contributes to protection against invasive pneumococcal infection originating from nasal colonization

ABSTRACT Streptococcus pneumoniae asymptomatically colonizes upper respiratory mucosa and invades into deeper tissue through mucosal membrane. Invasive pneumococcal disease has a significantly high rate of mortality, making its control an urgent concern. Mucin is a defensive system against respiratory infection. However, the role of transmembrane mucin against the development of invasive infection has been unclear. In this study, we demonstrate the roles of Muc16 on invasive pneumococcal disease. Muc16 knockout mice had significantly increased bacterial loads in the lungs and brain after nasal pneumococcal challenge, whereas bacterial loads in the nasal cavity had no difference. Under cigarette smoke extract (CSE)-pretreated conditions, they showed increased bacterial loads in the blood with the elevation of serum IL-6 level and a significant increase in the mortality rate. Infiltration of polymorphonuclear leukocytes was suppressed by deficiency of Muc16. The proportion of mucosal disruption in the olfactory epithelium was significantly increased by deficiency of Muc16, and the expression of tight junction molecule ZO-1 was inhibited in CSE-pretreated Muc16 knockout mice. Muc16 is, thus, considered to be essential for preserving the defensive system against pneumococcal translocation from nasal mucosa by regulating inflammatory cell infiltration and mucosal barrier integrity in the upper respiratory tract. MUC16 could be a new target in preventive strategy against pneumococcal infection. IMPORTANCE Streptococcus pneumoniae commonly colonizes the upper respiratory tract without causing symptoms but can sometimes invade deeper tissues and lead to life-threatening diseases, such as pneumonia, bacteremia, and meningitis. The mechanisms that prevent bacteria from spreading beyond the nasal mucosa are still incompletely understood. In this study, we demonstrate that the transmembrane mucin MUC16 plays an important role in protecting against invasive pneumococcal infection. Using a mouse model, we show that loss of Muc16 does not alter nasal colonization but increases bacterial dissemination to systemic organs and worsens survival, particularly under cigarette smoke exposure. Our findings suggest that MUC16 contributes to mucosal defense by maintaining epithelial barrier integrity and supporting neutrophil recruitment at the nasal surface. These results highlight the importance of transmembrane mucins in preventing bacterial invasion and provide new insight into how disruption of mucosal barriers may promote invasive pneumococcal disease.

Authors

Institutions

Publication Details

Journal
Microbiology Spectrum
Published
2026-06-26
DOI
https://doi.org/10.1128/spectrum.00824-26
Primary Topic
Glycosylation and Glycoproteins Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Muc16 contributes to protection against invasive pneumococcal infection originating from nasal colonization

Hiroki Kuwazoe, Hideki Sakatani, Takuro Iyo, Shizuya Saika et al.
Microbiology Spectrum
Glycosylation and Glycoproteins Research
article

Muc16 contributes to protection against invasive pneumococcal infection originating from nasal colonization

Hiroki Kuwazoe, Hideki Sakatani, Takuro Iyo, Shizuya Saika, Masamitsu Kono, Tatsuya Shiga, Daichi Murakami, Muneki Hotomi, Ryo Ueda, Kazuya Mizobata
article en

Abstract

ABSTRACT Streptococcus pneumoniae asymptomatically colonizes upper respiratory mucosa and invades into deeper tissue through mucosal membrane. Invasive pneumococcal disease has a significantly high rate of mortality, making its control an urgent concern. Mucin is a defensive system against respiratory infection. However, the role of transmembrane mucin against the development of invasive infection has been unclear. In this study, we demonstrate the roles of Muc16 on invasive pneumococcal disease. Muc16 knockout mice had significantly increased bacterial loads in the lungs and brain after nasal pneumococcal challenge, whereas bacterial loads in the nasal cavity had no difference. Under cigarette smoke extract (CSE)-pretreated conditions, they showed increased bacterial loads in the blood with the elevation of serum IL-6 level and a significant increase in the mortality rate. Infiltration of polymorphonuclear leukocytes was suppressed by deficiency of Muc16. The proportion of mucosal disruption in the olfactory epithelium was significantly increased by deficiency of Muc16, and the expression of tight junction molecule ZO-1 was inhibited in CSE-pretreated Muc16 knockout mice. Muc16 is, thus, considered to be essential for preserving the defensive system against pneumococcal translocation from nasal mucosa by regulating inflammatory cell infiltration and mucosal barrier integrity in the upper respiratory tract. MUC16 could be a new target in preventive strategy against pneumococcal infection. IMPORTANCE Streptococcus pneumoniae commonly colonizes the upper respiratory tract without causing symptoms but can sometimes invade deeper tissues and lead to life-threatening diseases, such as pneumonia, bacteremia, and meningitis. The mechanisms that prevent bacteria from spreading beyond the nasal mucosa are still incompletely understood. In this study, we demonstrate that the transmembrane mucin MUC16 plays an important role in protecting against invasive pneumococcal infection. Using a mouse model, we show that loss of Muc16 does not alter nasal colonization but increases bacterial dissemination to systemic organs and worsens survival, particularly under cigarette smoke exposure. Our findings suggest that MUC16 contributes to mucosal defense by maintaining epithelial barrier integrity and supporting neutrophil recruitment at the nasal surface. These results highlight the importance of transmembrane mucins in preventing bacterial invasion and provide new insight into how disruption of mucosal barriers may promote invasive pneumococcal disease.

Microbiology Spectrum
Wakayama Medical University (JP)
Research Promotion Foundation, Smoking Research Foundation, Wakayama Medical University, Shionogi, Japan Society for the Promotion of Science, Shionogi Infectious Disease Research Promotion Foundation
Good health and well-being
Openalex Percentile: Top 11%
Glycosylation and Glycoproteins Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.